A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK

Oncogene

Volumn 31, Issue 28, 2012, Pages 3333-3345

  Piskunov, A ^a   Rochette Egly, C ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

G alpha Q; lipid rafts; p38MAPK; RAR; retinoic acid

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE LIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIPID RAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HUMANS; MEMBRANE MICRODOMAINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR, ERBB-2; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 84863786925     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.499     Document Type: Article

References (53)

1. Alsayed Y, Uddin S, Mahmud N, Lekmine F, Kalvakolanu DV, Minucci S et al. (2001). Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 276: 4012-4019.
2. Altucci L, Leibowitz MD, Ogilvie KM, de Lera AR, Gronemeyer H. (2007). RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Discov 6: 793-810. (Pubitemid 47504871)
3. Bastien J, Rochette-Egly C. (2004). Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328: 1-16. (Pubitemid 38352876)
4. Bour G, Gaillard E, Bruck N, Lalevee S, Plassat JL, Busso D et al. (2005). Cyclin H binding to the RAR{alpha} activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7. Proc Natl Acad Sci USA 102: 16608-16613. (Pubitemid 41688824)
5. Bruck N, Vitoux D, Ferry C, Duong V, Bauer A, de The H et al. (2009). A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters. EMBO J 28: 34-47.
6. Chen N, Napoli JL. (2008). All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RARalpha. FASEB J 22: 236-245.
7. Clagett-Dame M, Knutson D. (2011). Vitamin A in reproduction and development. Nutrients 3: 385-428.
8. de Laurentiis A, Donovan L, Arcaro A. (2007). Lipid rafts and caveolae in signaling by growth factor receptors. Open Biochem J 1: 12-32.
9. Dey N, De PK, Wang M, Zhang H, Dobrota EA, Robertson KA et al. (2007). CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation. Mol Cell Biol 27: 4179-4197. (Pubitemid 47018068)
10. Duong V, Rochette-Egly C. (2011). The molecular physiology of nuclear retinoic acid receptors. From health to disease. Biochim Biophys Acta 1812: 1023-1031.
11. Faria TN, Mendelsohn C, Chambon P, Gudas LJ. (1999). The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274: 26783-26788.
12. Gaub MP, Rochette-Egly C, Lutz Y, Ali S, Matthes H, Scheuer I et al. (1992). Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res 201: 335-346.
13. Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M et al. (2006a). International Union of Pharmacology. LX. Retinoic acid receptors. Pharmacol Rev 58: 712-725. (Pubitemid 44833741)
14. Germain P, Staels B, Dacquet C, Spedding M, Laudet V. (2006b). Overview of nomenclature of nuclear receptors. Pharmacol Rev 58: 685-704. (Pubitemid 44833739)
15. Gianni M, Bauer A, Garattini E, Chambon P, Rochette-Egly C. (2002). Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-indced RARg degradation and transactivation. EMBO J 21: 3760-3769. (Pubitemid 34787049)
16. Gianni M, Parrella E, Raska I, Gaillard E, Nigro EA, Gaudon C et al. (2006). P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription. EMBO J 25: 739-751. (Pubitemid 43292436)
17. Huhtakangas JA, Olivera CJ, Bishop JE, Zanello LP, Norman AW. (2004). The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18: 2660-2671. (Pubitemid 39482056)
18. Lai L, Yuan L, Chen Q, Dong C, Mao L, Rowan B et al. (2008). The G alpha i and G alpha q proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation. J Pineal Res 45: 476-488.
19. Laudet V, Gronemeyer H. (2001). Nuclear Receptor Factsbook. Academic Press: London.
20. Le Romancer M, Treilleux I, Leconte N, Robin-Lespinasse Y, Sentis S, Bouchekioua-Bouzaghou K et al. (2008). Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol Cell 31: 212-221. (Pubitemid 352005820)
21. Lefebvre P, Martin PJ, Flajollet S, Dedieu S, Billaut X, Lefebvre B. (2005). Transcriptional activities of retinoic acid receptors. Vitam Horm 70: 199-264. (Pubitemid 43589019)
22. Losel R, Wehling M. (2003). Nongenomic actions of steroid hormones. Nat Rev Mol Cell Biol 4: 46-56. (Pubitemid 36077256)
23. Luoma JI, Boulware MI, Mermelstein PG. (2008). Caveolin proteins and estrogen signaling in the brain. Mol Cell Endocrinol 290: 8-13.
24. Marquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. (2006). Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol 246: 91-100. (Pubitemid 43238401)
25. Masia S, Alvarez S, de Lera AR, Barettino D. (2007). Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3- kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol 21: 2391-2402. (Pubitemid 47529353)
26. Matthews L, Berry A, Ohanian V, Ohanian J, Garside H, Ray D. (2008). Caveolin mediates rapid glucocorticoid effects and couples glucocorticoid action to the antiproliferative program. Mol Endocrinol 22: 1320-1330. (Pubitemid 351786993)
27. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M et al. (1998). Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17: 2008-2018. (Pubitemid 28154530)
28. Mizuno N, Itoh H. (2009). Functions and regulatory mechanisms of Gq-signaling pathways. Neurosignals 17: 42-54.
29. Norman AW, Henry HL, Bishop JE, Song XD, Bula C, Okamura WH. (2001). Different shapes of the steroid hormone 1alpha, 25(OH)(2)-vitamin D(3) act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 66: 147-158. (Pubitemid 32140894)
30. Norman AW, Mizwicki MT, Norman DP. (2004). Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3: 27-41. (Pubitemid 38088696)
31. Ordonez-Moran P, Larriba MJ, Palmer HG, Valero RA, Barbachano A, Dunach M et al. (2008). RhoA-ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells. J Cell Biol 183: 697-710.
32. Ostrom RS, Insel PA. (2006). Methods for the study of signaling molecules in membrane lipid rafts and caveolae. Methods Mol Biol 332: 181-191.
33. Pan J, Kao YL, Joshi S, Jeetendran S, Dipette D, Singh US. (2005). Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J Neurochem 93: 571-583. (Pubitemid 40617617)
34. Park SS, Kim JE, Kim YA, Kim YC, Kim SW. (2005). Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast. Histopathology 47: 625-630. (Pubitemid 41775186)
35. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. (2007). A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem 282: 22278-22288. (Pubitemid 47267344)
36. Pike LJ. (2003). Lipid rafts: bringing order to chaos. J Lipid Res 44: 655-667.
37. Piskunov A, Rochette-Egly C. (2011). MSK1 and Nuclear Receptors Signaling. In: Vermeulen L and Arthur JSC (eds). MSKs. Landes Bioscience Books: Austin, TX, USA.
38. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK et al. (2003). Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23: 9529-9540. (Pubitemid 37352053)
39. Rochette-Egly C, Germain P. (2009). Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors. Nucl Receptor Signaling 7: e005.
40. Rochette-Egly C, Plassat JL, Taneja R, Chambon P. (2000). The AF-1 and AF-2 activating domains of retinoic acid receptoralpha (RARalpha) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes. Mol Endocrinol 14: 1398-1410.
41. Samarut E, Rochette-Egly C. (2011). Nuclear retinoic acid receptors: conductors of the retinoic acid symphony during development. Mol Cell Endocrinol (e-pub ahead of print 8 April 2011).
42. Simons K, Toomre D. (2000). Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39.
43. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J et al. (2006). Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3: 995-1000. (Pubitemid 44782698)
44. Staubach S, Hanisch FG. (2011). Lipid rafts: signaling and sorting platforms of cells and their roles in cancer. Expert Rev Proteomics 8: 263-277.
45. Stuermer CA. (2011). Reggie/flotillin and the targeted delivery of cargo. J Neurochem 116: 708-713.
46. Sugawara Y, Nishii H, Takahashi T, Yamauchi J, Mizuno N, Tago K et al. (2007). The lipid raft proteins flotillins/reggies interact with G alpha q and are involved in Gq-mediated p38 mitogen-activated protein kinase activation through tyrosine kinase. Cell Signal 19: 1301-1308. (Pubitemid 46561566)
47. Taneja R, Rochette-Egly C, Plassat JL, Penna L, Gaub MP, Chambon P. (1997). Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment. EMBO J 16: 6452-6465. (Pubitemid 27483271)
48. Tari AM, Lim SJ, Hung MC, Esteva FJ, Lopez-Berestein G. (2002). Her2/neu induces all-trans retinoic acid (ATRA) resistance in breast cancer cells. Oncogene 21: 5224-5232. (Pubitemid 34948134)
49. Vasudevan N, Pfaff DW. (2008). Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front Neuroendocrinol 29: 238-257.
50. Waugh MG, Hsuan JJ. (2009). Preparation of membrane rafts. Methods Mol Biol 462: 403-414.
51. White CD, Coetsee M, Morgan K, Flanagan CA, Millar RP, Lu ZL. (2008). A crucial role for G alpha q/11, but not G alpha i/o or G alpha s, in gonadotropin-releasing hormone receptor-mediated cell growth inhibition. Mol Endocrinol 22: 2520-2530.
52. Yao Y, Hong S, Zhou H, Yuan T, Zeng R, Liao K. (2009). The differential protein and lipid compositions of noncaveolar lipid microdomains and caveolae. Cell Res 19: 497-506.
53. Zanotto-Filho A, Cammarota M, Gelain DP, Oliveira RB, Delgado- Canedo A, Dalmolin RJ et al. (2008). Retinoic acid induces apoptosis by a non-classical mechanism of ERK1/2 activation. Toxicol In Vitro 22: 1205-1212.